Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
This guide discusses reliability factors for leading indicators and how to assess their trustworthiness in different economic contexts.
13,619 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
The MBA reports a 1.0% weekly rise in mortgage applications, driven by refinancing activity as rates paused near 6.6%...
The Senate backed a symbolic war-powers resolution in a tight 50-48 vote, signaling bipartisan unease with Trump-era ...
Apple reported a strong quarter with better-than-expected growth across iPhone and Services. Analysts say apple’s tar...
Two former governors unveil a bipartisan coalition designed to prepare America’s workforce for an AI-driven future, w...
Regulated banks can custody crypto and settle tokenized funds, but Basel's capital rules impose a punishing cost that...
Bitcoin found itself at a fresh test of a long standing benchmark after slipping below a key line used by traders to ...
World Cup bets on Polymarket surged to $3.3 billion in trading volume, eclipsing the Super Bowl and drawing attention...
Tavant launches a new agentic AI platform aimed at accelerating loan software development, data modernization, and au...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Could SpaceX become a defining winner in a new era of commercial space? This guide breaks down how buying SpaceX toda...
Tesla accelerates margin gains in Q1 2026 as Rivian pushes its R2 strategy through partnerships and new products, hig...